Randomized Placebo-Controlled Study of ISA247 in Plaque Psoriasis (SPIRIT)

This study has been completed.

Sponsor:

Information provided by:

Aurinia Pharmaceuticals Inc.

ClinicalTrials.gov Identifier:

NCT00244842

First received: October 25, 2005

Last updated: September 24, 2008

Last verified: September 2008

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	October 2005
Primary Completion Date:	October 2005 (Final data collection date for primary outcome measure)

No publications provided by Aurinia Pharmaceuticals Inc.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Papp K, Bissonnette R, Rosoph L, Wasel N, Lynde CW, Searles G, Shear NH, Huizinga RB, Maksymowych WP. Efficacy of ISA247 in plaque psoriasis: a randomised, multicentre, double-blind, placebo-controlled phase III study. Lancet. 2008 Apr 19;371(9621):1337-42. doi: 10.1016/S0140-6736(08)60593-0.

To Top